检验医学 ›› 2023, Vol. 38 ›› Issue (10): 987-996.DOI: 10.3969/j.issn.1673-8640.2023.10.016
郭霜, 刘红莉, 李娅
收稿日期:
2022-09-18
修回日期:
2023-06-10
出版日期:
2023-10-30
发布日期:
2023-12-18
作者简介:
郭霜,女,1992年生,硕士,检验技师,主要从事临床检验工作。
基金资助:
GUO Shuang, LIU Hongli, LI Ya
Received:
2022-09-18
Revised:
2023-06-10
Online:
2023-10-30
Published:
2023-12-18
摘要:
胃癌是全球第五大常见恶性肿瘤,死亡率居肿瘤相关死亡的第3位。EB病毒(EBV)感染在人群中非常普遍,与各种人类肿瘤有关,如鼻咽癌、胃癌和淋巴瘤,其中EB病毒相关胃癌(EBVaGC)约占所有胃癌的1.3%~30.9%。在EBV相关肿瘤中,许多非编码RNA(ncRNA)参与了肿瘤细胞增殖、迁移和侵袭等过程的调控,ncRNA与潜在靶基因的相互作用逐渐成为研究热点。文章综述了与胃癌迁移、侵袭相关的ncRNA的研究进展,以期为后续胃癌的研究提供参考。
中图分类号:
郭霜, 刘红莉, 李娅. EB病毒相关胃癌迁移、侵袭相关miRNA和lncRNA研究进展[J]. 检验医学, 2023, 38(10): 987-996.
GUO Shuang, LIU Hongli, LI Ya. Progression of migration and invasion-related miRNA and lncRNA in Epstein-Barr virus-associated gastric cancer[J]. Laboratory Medicine, 2023, 38(10): 987-996.
EBV ncRNA | 结合靶点 | 宿主ncRNA | 迁移侵袭 | 凋亡 | EMT | 信号通路/信号轴 |
---|---|---|---|---|---|---|
miR-BART1-3p[ | PTEN,DAB2 | 促进 | 抑制 | PI3K/Akt,Akt/FAK/p130和Shc/MAPK通路 | ||
miR-BART1-5p[ | PTEN | 促进 | 促进 | PI3K-Akt,Akt/FAK/p130和Shc/MAPK通路 | ||
miR-BART2-5p[ | RB,p21 | 促进 | ||||
miR-BART3-3p[ | p21 | 促进 | ||||
miR-BART3-5p[ | DICE1 | 促进 | ||||
miR-BART4-5p[ | PTEN,Bid | 促进 | 抑制 | |||
miR-BART5-3p[ | p53 | 抑制 | ||||
miR-BART5-5p[ | PUMA,PIAS3 | 促进 | 抑制 | miR-BART5/PIAS3/pSTAT3/PD-L1 | ||
miR-BART6-3p[ | Lnc-LOC553103 | 抑制 | 促进 | LOC553103-STMN1信号轴 | ||
miR-BART7[ | Snail,β-catenin | 促进 | ||||
miR-BART8-3p[ | RNF38 | 促进 | NF-κB和ERK1/2信号通路 | |||
miR-BART9-3p[ | CDH1 | hsa-miR-200a hsa-miR-141 | 促进 | miR-200/ZEB1/E-Cad信号轴 | ||
miR-BART9-5p[ | CDH1 | hsa-miR-200a hsa-miR-141 | 促进 | miR-200/ZEB1/E-Cad信号轴 | ||
miR-BART10-3p[ | APC,DKK1,BTRC | 促进 | 促进 | 激活Wnt信号通路 | ||
miR-BART11[ | Foxp1,RB,p21 | 促进 | 促进 | |||
miR-BART15[ | TAX1BP1,NLRP3,TAX1BP1 | 抑制 | 促进 | |||
miR-BART17-5p[ | KLF2,LMP2A | 促进 | ||||
miR-BART20-5p[ | BAD | 促进 | 抑制 | |||
miR-BART22[ | APC,DKK1,LMP2A | 促进 | 激活Wnt信号通路 | |||
circRNA-LMP2A[ | hsa-miR-3908 | 促进 | KHSRP/VHL/HIF-1α/VEGFA信号轴 | |||
circRNA-RPMS1[ | METTL3 | 促进 |
表1 胃癌恶性表型相关的EBV ncRNA与宿主ncRNA
EBV ncRNA | 结合靶点 | 宿主ncRNA | 迁移侵袭 | 凋亡 | EMT | 信号通路/信号轴 |
---|---|---|---|---|---|---|
miR-BART1-3p[ | PTEN,DAB2 | 促进 | 抑制 | PI3K/Akt,Akt/FAK/p130和Shc/MAPK通路 | ||
miR-BART1-5p[ | PTEN | 促进 | 促进 | PI3K-Akt,Akt/FAK/p130和Shc/MAPK通路 | ||
miR-BART2-5p[ | RB,p21 | 促进 | ||||
miR-BART3-3p[ | p21 | 促进 | ||||
miR-BART3-5p[ | DICE1 | 促进 | ||||
miR-BART4-5p[ | PTEN,Bid | 促进 | 抑制 | |||
miR-BART5-3p[ | p53 | 抑制 | ||||
miR-BART5-5p[ | PUMA,PIAS3 | 促进 | 抑制 | miR-BART5/PIAS3/pSTAT3/PD-L1 | ||
miR-BART6-3p[ | Lnc-LOC553103 | 抑制 | 促进 | LOC553103-STMN1信号轴 | ||
miR-BART7[ | Snail,β-catenin | 促进 | ||||
miR-BART8-3p[ | RNF38 | 促进 | NF-κB和ERK1/2信号通路 | |||
miR-BART9-3p[ | CDH1 | hsa-miR-200a hsa-miR-141 | 促进 | miR-200/ZEB1/E-Cad信号轴 | ||
miR-BART9-5p[ | CDH1 | hsa-miR-200a hsa-miR-141 | 促进 | miR-200/ZEB1/E-Cad信号轴 | ||
miR-BART10-3p[ | APC,DKK1,BTRC | 促进 | 促进 | 激活Wnt信号通路 | ||
miR-BART11[ | Foxp1,RB,p21 | 促进 | 促进 | |||
miR-BART15[ | TAX1BP1,NLRP3,TAX1BP1 | 抑制 | 促进 | |||
miR-BART17-5p[ | KLF2,LMP2A | 促进 | ||||
miR-BART20-5p[ | BAD | 促进 | 抑制 | |||
miR-BART22[ | APC,DKK1,LMP2A | 促进 | 激活Wnt信号通路 | |||
circRNA-LMP2A[ | hsa-miR-3908 | 促进 | KHSRP/VHL/HIF-1α/VEGFA信号轴 | |||
circRNA-RPMS1[ | METTL3 | 促进 |
[1] |
SMYTH E C, NILSSON M, GRABSCH H I, et al. Gastric cancer[J]. Lancet, 2020, 396(10251):635-648.
DOI PMID |
[2] |
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma[J]. Nature, 2014, 513(7517):202-209.
DOI |
[3] | 路晴晴, 金玲玲, 赵燕, 等. EBV miRNA在EBV相关胃癌中的作用机制研究进展[J]. 临床消化病杂志, 2019, 31(3):182-186. |
[4] |
YANG J, LIU Z, ZENG B, et al. Epstein-Barr virus-associated gastric cancer:a distinct subtype[J]. Cancer Lett, 2020, 495:191-199.
DOI URL |
[5] |
KANDA T. EBV-encoded latent genes[J]. Adv Exp Med Biol, 2018, 1045:377-394.
DOI PMID |
[6] |
SHECHTER O, SAUSEN D G, GALLO E S, et al. Epstein-Barr virus(EBV) epithelial associated malignancies:exploring pathologies and current treatments[J]. Int J Mol Sci, 2022, 23(22):14389.
DOI URL |
[7] |
TAM C, WONG J H, TSUI S K W, et al. LncRNAs with miRNAs in regulation of gastric,liver,and colorectal cancers:updates in recent years[J]. Appl Microbiol Biotechnol, 2019, 103(12):4649-4677.
DOI |
[8] |
IIZASA H, KARTIKA A V, FEKADU S, et al. Development of Epstein-Barr virus-associated gastric cancer:infection,inflammation,and oncogenesis[J]. World J Gastroenterol, 2022, 28(44):6249-6257.
DOI URL |
[9] |
TORRES K, LANDEROS N, WICHMANN I A, et al. EBV miR-BARTs and human lncRNAs:shifting the balance in competing endogenous RNA networks in EBV-associated gastric cancer[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(4):166049.
DOI URL |
[10] |
KIM D N, CHAE H S, OH S T, et al. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma[J]. J Virol, 2007, 81(2):1033-1036.
PMID |
[11] |
LIN C, ZONG J, LIN W, et al. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways[J]. J Exp Clin Cancer Res, 2018, 37(1):283.
DOI PMID |
[12] |
MIN K, LEE S K. EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1[J]. Int J Biol Sci, 2019, 15(3):657-667.
DOI PMID |
[13] | DONG M, GONG L, CHEN J, et al. EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway[J]. Cell Oncol(Dordr), 2020, 43(5):901-913. |
[14] |
CAI L, YE Y, JIANG Q, et al. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma[J]. Nat Commun, 2015, 6:7353.
DOI PMID |
[15] |
YOON J H, MIN K, LEE S K. Epstein-Barr virus miR-BART17-5p promotes migration and anchorage-independent growth by targeting kruppel-like factor 2 in gastric cancer[J]. Microorganisms, 2020, 8(2):258.
DOI URL |
[16] |
LUNG R W, TONG J H, SUNG Y M, et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22[J]. Neoplasia, 2009, 11(11):1174-1184.
DOI URL |
[17] |
ZHAO M, LIU W, ZHANG X, et al. Epstein-Barr virus miR-BART2-5p and miR-BART11-5p regulate cell proliferation,apoptosis,and migration by targeting RB and p21 in gastric carcinoma[J]. J Med Virol, 2023, 95(1):e28338.
DOI URL |
[18] |
SONG Y, LI Q, LIAO S, et al. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer[J]. Virology, 2020, 548:6-16.
DOI PMID |
[19] |
LEI T, YUEN K S, XU R, et al. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma[J]. Int J Cancer, 2013, 133(1):79-87.
DOI PMID |
[20] |
YOON C J, CHANG M S, KIM D H, et al. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation,worsening clinical outcomes of PD-L1-positive gastric carcinomas[J]. Gastric Cancer, 2020, 23(5):780-795.
DOI |
[21] |
SAITOH M. Involvement of partial EMT in cancer progression[J]. J Biochem, 2018, 164(4):257-264.
DOI PMID |
[22] | BUSUIOC C, BIRLA R D, ULTIMESCU F, et al. Abberant immunohistochemical expression of OCT3/4 and EMT related markers,vimentin and E-cadherin,is correlated with adverse histopathological features in colorectal adenocarcinoma[J]. Chirurgia(Bucur), 2022, 117(5):544-555. |
[23] |
HSU C, YI Y, CHANG K P, et al. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma[J]. PLoS Pathog, 2014, 10(2):e1003974.
DOI URL |
[24] | TSAI C, LIU Y, LIU K, et al. Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma:highlighting the interactions of EBV-Bart9 and host tumor cells[J]. J Gastroenterol Hepatol, 2017, 32(1):82-91. |
[25] |
YAN Q, ZENG Z, GONG Z, et al. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC[J]. Oncotarget, 2015, 6(39):41766-41782.
DOI PMID |
[26] |
CAI L, LYU X, LUO W, et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN[J]. Oncogene, 2015, 34(17):2156-2166.
DOI PMID |
[27] |
SONG Y, LI Q, LIAO S, et al. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer[J]. Virology, 2020, 548:6-16.
DOI PMID |
[28] |
CHOI H, LEE S K. TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU[J]. Arch Virol, 2017, 162(2):369-377.
DOI PMID |
[29] |
MIN K, KIM J Y, LEE S K. Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2[J]. Int J Biol Sci, 2020, 16(4):694-707.
DOI PMID |
[30] | ZHENG X, WANG J, WEI L, et al. Epstein-Barr virus microRNA miR-BART5-3p inhibits p53 expression[J]. J Virol, 2018, 92(23):e01022-18. |
[31] |
FEEDERLE R, LINNSTAEDT S D, BANNERT H, et al. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus[J]. PLoS Pathog, 2011, 7(2):e1001294.
DOI URL |
[32] |
CHOY E Y, SIU K L, KOK K H, et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival[J]. J Exp Med, 2008, 205(11):2551-2560.
DOI URL |
[33] |
SHINOZAKI-USHIKU A, KUNITA A, ISOGAI M, et al. Profiling of virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis[J]. J Virol, 2015, 89(10):5581-5591.
DOI URL |
[34] |
KIM H, CHOI H, LEE S K. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD[J]. Cancer Lett, 2015, 356(2 Pt B):733-742.
DOI PMID |
[35] |
WANG D, ZENG Z, ZHANG S, et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis[J]. FASEB J, 2020, 34(6):8012-8027.
DOI PMID |
[36] |
MARQUITZ A R, MATHUR A, CHUGH P E, et al. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells[J]. J Virol, 2014, 88(2):1389-1393.
DOI PMID |
[37] |
KIM S M, HUR D Y, HONG S W, et al. EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells[J]. Biochem Biophys Res Commun, 2017, 494(3-4):550-555.
DOI URL |
[38] |
TREECE A L, DUNCAN D L, TANG W, et al. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns[J]. Lab Invest, 2016, 96(6):661-671.
DOI PMID |
[39] |
HUANG X, XIAO S, ZHU X, et al. MiR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling[J]. Cell Death Dis, 2020, 11(9):785.
DOI PMID |
[40] |
WANG P, ZHUANG L, ZHANG J, et al. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer,and miR-21 expression confers chemoresistance by targeting FasL[J]. Mol Oncol, 2013, 7(3):334-345.
DOI URL |
[41] |
WANG H, YU X, LIU Z, et al. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3[J]. J Pathol, 2011, 225(2):232-242.
DOI URL |
[42] |
SHINOZAKI A, SAKATANI T, USHIKU T, et al. Downregulation of microRNA-200 in EBV-associated gastric carcinoma[J]. Cancer Res, 2010, 70(11):4719-4727.
DOI PMID |
[43] |
ZHANG J, LI X, HU J, et al. Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis[J]. Virol J, 2020, 17(1):51.
DOI PMID |
[44] |
VERHOEVEN R J A, TONG S, MOK B W, et al. Epstein-Barr virus BART long non-coding RNAs function as epigenetic modulators in nasopharyngeal carcinoma[J]. Front Oncol, 2019, 9:1120.
DOI PMID |
[45] |
RENNEKAMP A J, LIEBERMAN P M. Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt[J]. J Virol, 2011, 85(6):2837-2850.
DOI PMID |
[46] | YETMING K D, LUPEY-GREEN L N, BIRYUKOV S, et al. The BHLF1 locus of Epstein-Barr virus contributes to viral latency and B-cell immortalization[J]. J Virol, 2020, 94(17):e01215-e01220. |
[47] | PARK R, MILLER G. Epstein-Barr virus-induced nodules on viral replication compartments contain RNA processing proteins and a viral long noncoding RNA[J]. J Virol, 2018, 92(20):e01254-18. |
[48] |
YUAN X, YAN Y, XUE M. Small nucleolar RNA host gene 8:a rising star in the targets for cancer therapy[J]. Biomed Pharmacother, 2021, 139:111622.
DOI URL |
[49] |
HUANG T, JI Y, HU D, et al. SNHG8 is identified as a key regulator of Epstein-Barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression[J]. Oncotarget, 2016, 7(49):80990-81002.
DOI PMID |
[50] |
ZOU C, LIAO J, HU D, et al. SNHG8 promotes the progression of Epstein-Barr virus-associated gastric cancer via sponging miR-512-5p and targeting TRIM28[J]. Front Oncol, 2021, 11:734694.
DOI URL |
[51] | 陈宝珍, 林贤东, 陈刚, 等. 长链非编码 RNA SNHG8在 EB 病毒相关胃癌中的表达及其临床意义[J]. 中华病理学杂志, 2017, 46(2):89-92. |
[52] |
SHI B, WANG Y, YIN F. MALAT1/miR-124/Capn4 axis regulates proliferation,invasion and EMT in nasopharyngeal carcinoma cells[J]. Cancer Biol Ther, 2017, 18(10):792-800.
DOI URL |
[53] |
THOMSON D W, DINGER M E. Endogenous microRNA sponges:evidence and controversy[J]. Nat Rev Genet, 2016, 17(5):272-283.
DOI |
[54] |
KIM B G, KANG S, HAN H H, et al. Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets[J]. Oncotarget, 2016, 7(19):27468-27478.
DOI PMID |
[55] |
YAN S, HAN B, GAO S, et al. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer[J]. Oncotarget, 2017, 8(36):60149-60158.
DOI PMID |
[56] |
WANG H, ZHANG M, SUN G. Long non-coding RNA NEAT1 regulates the proliferation,migration and invasion of gastric cancer cells via targeting miR-335-5p/ROCK1 axis[J]. Pharmazie, 2018, 73(3):150-155.
DOI URL |
[57] |
GONG C, TANG R, LIU K, et al. Long non-coding RNA TP73-AS1 in cancers[J]. Clin Chim Acta, 2020, 503:151-156.
DOI URL |
[58] |
JING J, WANG Z, LI H, et al. Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation[J]. Cancer Cell Int, 2018, 18:146.
DOI |
[59] |
LIU X, SUN M, NIE F, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer[J]. Mol Cancer, 2014, 13:92.
DOI |
[60] |
HU Y, YU Y, YOU S, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer[J]. Mol Cancer, 2017, 16(1):174.
DOI PMID |
[61] |
LI C, HU J, HAO J, et al. Competitive virus and host RNAs:the interplay of a hidden virus and host interaction[J]. Protein Cell, 2014, 5(5):348-356.
DOI URL |
[62] |
LI C, WANG Y, WANG S, et al. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein,which promotes hepatocellular carcinoma tumor growth and cell invasion[J]. J Virol, 2013, 87(4):2193-2205.
DOI URL |
[63] |
GUNASEKHARAN V, LAIMINS L A. Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification[J]. J Virol, 2013, 87(10):6037-6043.
DOI PMID |
[64] |
HE B, LI W, WU Y, et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103[J]. Cell Death Dis, 2016, 7(9):e2353.
DOI |
[65] |
UNGERLEIDER N, CONCHA M, LIN Z, et al. The Epstein Barr virus circRNAome[J]. PLoS Pathog, 2018, 14(8):e1007206.
DOI URL |
[66] | TOPTAN T, ABERE B, NALESNIK M A, et al. Circular DNA tumor viruses make circular RNAs[J]. Proc Natl Acad Sci U S A, 2018, 115(37):E8737-E8745. |
[67] |
LIU D, SHI D, XU L, et al. LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma[J]. Virus Res, 2022, 315:198792.
DOI URL |
[68] |
GONG L, CHEN J, DONG M, et al. Epstein-Barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer[J]. EMBO Rep, 2020, 21(10):e49689.
DOI URL |
[69] |
ZHANG J, DU Y, GONG L, et al. EBV-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3[J]. Cancer Lett, 2022, 535:215646.
DOI URL |
[70] |
IWAKIRI D. Multifunctional non-coding Epstein-Barr virus encoded RNAs(EBERs) contribute to viral pathogenesis[J]. Virus Res, 2016, 212:30-38.
DOI URL |
[71] |
AYEE R, OFORI M E O, WRIGHT E, et al. Epstein Barr virus associated lymphomas and epithelia cancers in humans[J]. J Cancer, 2020, 11(7):1737-1750.
DOI PMID |
[72] | IWAKIRI D. Epstein-Barr virus-encoded RNAs:key molecules in viral pathogenesis[J]. Cancers(Basel), 2014, 6(3):1615-1630. |
[73] |
LI Z, DUAN Y, CHENG S, et al. EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma[J]. Oncotarget, 2015, 6(27):24291-24303.
PMID |
[1] | 沈希敏, 张雷, 权衡, 牛紫光, 夏冬歌, 张如霖. 血清lncRNA NEAT1在多发性骨髓瘤患者肾损伤的临床应用价值分析[J]. 检验医学, 2025, 40(1): 32-36. |
[2] | 向敏, 舒扬, 盛玉程, 武晓白, 郭若楠, 蒋一凡. 胃腺癌患者LHPP 表达及其对癌细胞生物学功能的影响[J]. 检验医学, 2025, 40(1): 41-48. |
[3] | 闫江泓, 王乐, 马琳, 杨硕, 郭巍巍, 赵梦川, 刘泽昊, 翟小颖. EB病毒感染急性淋巴细胞白血病患儿临床特征分析[J]. 检验医学, 2024, 39(6): 583-586. |
[4] | 张晓科, 褚艳荣, 王荣, 崔发财. 宫颈癌患者lncRNA HAND2-AS1表达及其对宫颈癌Caski细胞增殖、侵袭和迁移能力的影响[J]. 检验医学, 2024, 39(5): 429-437. |
[5] | 刘雪伟, 李鲲鹏, 宋君宇, 赵安. Apelin和IRS-2蛋白与胃癌患者预后的关系[J]. 检验医学, 2024, 39(5): 438-442. |
[6] | 方丹东, 程岗, 黄伟, 刘晓楠, 毛尖, 侯保森, 刘十岷. 脑胶质瘤组织lncRNA SOX21-AS1、miR-875-5p表达及其与患者预后的关系[J]. 检验医学, 2024, 39(3): 209-214. |
[7] | 陈寰, 董方, 吕志勇, 甄景慧, 陈梅, 苏建荣. 儿童侵袭性无乳链球菌血清型和耐药性分析[J]. 检验医学, 2024, 39(3): 260-264. |
[8] | 马晨, 张祎, 李芳, 王静, 陈葳. 儿童侵袭性肺炎链球菌病伴坏死性肺炎临床特点、耐药性和预后不良相关因素分析[J]. 检验医学, 2024, 39(3): 265-271. |
[9] | 田文杰, 吴文娟. 耶氏肺孢子菌合并EB病毒致肺部难治性感染1例报道[J]. 检验医学, 2024, 39(12): 1169-1172. |
[10] | 汪兆慧, 郑振鲁, 李瑞娜, 马媛媛, 徐辉, 魏振宏, 贾彦娟, 齐晓明, 高小玲. DosR抗原Rv2626c通过lncRNA MacORIS诱导巨噬细胞活化的结核潜伏感染机制研究[J]. 检验医学, 2024, 39(10): 923-932. |
[11] | 张菲斐, 王婧雯, 张跃欣, 郑大炜, 门翔. COPD患者lncRNA MIR155HG表达与肺功能的相关性及其对AECODP的辅助诊断价值[J]. 检验医学, 2024, 39(1): 31-36. |
[12] | 戴宏建, 崔海宁, 李艳凤, 崔红梅. miR-155-5p靶向ARID2对口腔鳞状细胞癌有促进作用[J]. 检验医学, 2024, 39(1): 87-94. |
[13] | 杨玉强, 全晓丽, 王刘玉, 鲜文峰, 杨红. 骨肉瘤组织RRBP1表达及其对细胞生物学特征的影响[J]. 检验医学, 2023, 38(9): 842-848. |
[14] | 赵沱, 白鹏飞, 孙婧, 程涛. 血清lncRNA NEAT1在急性心肌梗死患者中的表达及其临床意义[J]. 检验医学, 2023, 38(9): 897-900. |
[15] | 张娜, 牛伟华, 孙媛媛, 贾玫. CMV和EBV共感染可影响造血干细胞移植患者预后[J]. 检验医学, 2023, 38(8): 760-765. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||